Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This means survodutide may provide additional benefits for fat loss specifically, particularly visceral and liver fat, beyond what GIP/GLP-1 dual agonism achieves
In the 2026 ADA Scientific Sessions, results from the Phase-3 TRANSCEND-T2D-1 study involving retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors, showed up to a 2% decrease in A1C and a 16.8% decrease in body weight over 40 weeks in patients with type 2 diabetes
Supports Fat Metabolism This product is not just about providing an energy lift
Once reconstituted, the peptide must be refrigerated at 28C and used within 28 days
US$ 22.76
US$ 24.47
US$ 28.38
